The global allergy immunotherapy market size was valued at USD 1.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% during the forecast period 2021-2028.
Allergy immunotherapy is used for the treatment of allergic asthma, allergic rhinitis/conjunctivitis, and stringent insect hypersensitivity.
The rising prevalence of allergic disorders and their burden across the globe and Complex allergies with higher morbidity serve as a burden on the healthcare system are some of the factors that have supported long-term expansion for Allergy Immunotherapy Market.
The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. It is expected that the allergy immunotherapy market in the global market will recover from this global pandemic situation by the end of the second quarter and the beginning of the third quarter in the coming year during the forecasted period from 2017 to 2023.
Europe accounted for the largest share of 69.1% in 2019 and is expected to hold its position throughout the forecast period. However, Asia Pacific is projected to register the fastest CAGR throughout the forecast period.
Insights are provided for each region and major countries within the regions
|
Report Feature |
Descriptions |
|---|---|
|
Growth Rate |
CAGR of 9.0% during the forecasting period, 2021-2027 |
|
Historical Data |
2018-2019 |
|
Forecast Years |
2021-2027 |
|
Base Year |
2020 |
|
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2027 |
|
Report Segmentation |
material type, end use, implementation and geography |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
ASIT Biotech, Circassia, Mylan N.V., Adamis Pharmaceuticals Corporation, Merck KGaA, Stallergenes Greer plc, Allergy Therapeutics, ALK-Abelló A/S, DESENTUM OY, HAL Allergy B.V., HollisterStier Allergy, LETIPharma, and DBV Technologies SA. |
|
Available Customization |
In addition to the market data for Allergy Immunotherapy Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Allergy Immunotherapy Market is segmented into treatment type, allergy type, distribution channel and region.
.png)
.png)
.png)
.png)
.png)
.png)